2 assets in Thrombotic Thrombocytopenic Purpura

Therapeutic assets addressing Thrombotic Thrombocytopenic Purpura, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Immunoglobulin G1-Lambda2, Anti-(Severe Acute Respiratory Syndrome (Human) Coronavirus 2 (Sars-Cov-2) Spike (S) Glycoprotein, Receptor Binding Domain (Rbd)), Homo Sapiens Monoclonal Antibod Thrombotic Thrombocytopenic Purpura	Imperial College Healthcare NHS Trust	P2	CCC (53)
Ogalvibart Thrombotic Thrombocytopenic Purpura	Imperial College Healthcare NHS Trust	P2	CCC (53)